A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies.

Atmar, Robert L; Ettayebi, Khalil; Ramani, Sasirekha; Neill, Frederick H; Lindesmith, Lisa; Baric, Ralph S; Brinkman, Amanda; Braun, Ralph; Sherwood, James; Estes, Mary K

Atmar, Robert L; Ettayebi, Khalil; Ramani, Sasirekha; Neill, Frederick H; Lindesmith, Lisa; Baric, Ralph S; Brinkman, Amanda; Braun, Ralph; Sherwood, James; Estes, Mary K.

Afiliación

Atmar RL; Departments of Medicine and Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Ettayebi K; Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Ramani S; Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Neill FH; Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Lindesmith L; Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Baric RS; Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina, USA.
Brinkman A; Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina, USA.
Braun R; Takeda Vaccines Inc., Cambridge, MA, USA.
Sherwood J; Takeda Vaccines Inc., Cambridge, MA, USA.
Estes MK; Takeda Pharmaceuticals International AG, Zurich, Switzerland.

J Infect Dis ; 2023 Oct 02.

Article en En | MEDLINE | ID: mdl-37781879

Palabras clave

VLP; binding antibody; histoblood group antigen-blocking antibody; human norovirus; neutralizing antibody; vaccine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Infect Dis Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google